ArticleFrontiers in oncology2025
A rare case of mammary hamartoma presenting as malignant on radiological assessment and benign on pathological examination: a case report.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast hamartomas are rare, benign, and encapsulated lesions composed of a combination of fatty, glandular, muscular, and fibrous tissue. Mammography provides an overview of the breast's structure and can identify the characteristic "breast within a breast" appearance typical of hamartomas. Ultrasound is useful for determining the echogenicity and vascularization of hamartomas, thereby helping to differentiate them from potential malignancies. Magnetic Resonance Imaging (MRI) is another indispensable tool in the diagnostic arsenal for breast hamartomas. One of the major challenges in differential diagnosis is distinguishing hamartomas from fibroadenomas, which typically occur in young women. Here, we present a case of a 21-year-old female with a highly suspicious lesion based on radiological features, which was ultimately diagnosed histologically as a breast hamartoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.